Literature DB >> 27284343

Clinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis.

Keli He1, Hui Zeng1, Xianqun Xu1, Anling Li1, Qing Cai2, Xinghua Long1.   

Abstract

The aim of the present study was to investigate the associations between the expression of forkhead box protein A1 (FOXA1) and differential clinicopathological characteristics in breast cancer using a meta-analysis method. Eligible studies that investigated the correlation between FOXA1 expression and the clinical characteristics of breast cancer were collected through searching numerous databases, including PubMed, EMBASE, the Chinese National Knowledge Infrastructure and the VIP database. In total, eight studies were included in the meta-analysis. Following a systematic analysis, the expression of FOXA1 was found to be significantly associated with the estrogen receptor α status, the progesterone receptor status, lymph node metastasis and the histological grade in breast cancer. However, no statistically significant association was observed between FOXA1 expression and the human epidermal growth factor receptor-2 status in breast cancer patients.

Entities:  

Keywords:  breast cancer; forkhead box protein A1; meta-analysis

Year:  2016        PMID： 27284343      PMCID： PMC4887757          DOI： 10.3892/etm.2016.3229

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN： 1792-0981            Impact factor:   2.447


  32 in total

1.  Prognostic and Predictive Factors for Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  [Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].

Authors:  Ning Liu; Yun Niu; Shu-ling Wang; Qi Yu; Rong-ju Zhang; Tie-ju Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2010-05-25

4.  BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).

Authors:  E A Williamson; I Wolf; J O'Kelly; S Bose; S Tanosaki; H P Koeffler
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

5.  Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.

Authors:  Aurélien A Sérandour; Stéphane Avner; Frédéric Percevault; Florence Demay; Maud Bizot; Céline Lucchetti-Miganeh; Frédérique Barloy-Hubler; Myles Brown; Mathieu Lupien; Raphaël Métivier; Gilles Salbert; Jérôme Eeckhoute
Journal:  Genome Res       Date:  2011-01-13       Impact factor: 9.043

6.  The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

Authors:  Lin Lin; Charles T Miller; Jorge I Contreras; Michael S Prescott; Susan L Dagenais; Rong Wu; John Yee; Mark B Orringer; David E Misek; Samir M Hanash; Thomas W Glover; David G Beer
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 7.  FOXA1: a promising prognostic marker in breast cancer.

Authors:  Qing Hu; Zhou Luo; Tao Xu; Jun-Ying Zhang; Ying Zhu; Wei-Xian Chen; Shan-Liang Zhong; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Asian Pac J Cancer Prev       Date:  2014

8.  Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.

Authors:  Foluso O Ademuyiwa; Mangesh A Thorat; Rohit K Jain; Harikrishna Nakshatri; Sunil Badve
Journal:  Mod Pathol       Date:  2009-11-27       Impact factor: 7.842

Review 9.  FOXA1 in breast cancer.

Authors:  Harikrishna Nakshatri; Sunil Badve
Journal:  Expert Rev Mol Med       Date:  2009-03-05       Impact factor: 5.600

10.  FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.

Authors:  Yusuke Imamura; Shinichi Sakamoto; Takumi Endo; Takanobu Utsumi; Miki Fuse; Takahito Suyama; Koji Kawamura; Takashi Imamoto; Kojiro Yano; Katsuhiro Uzawa; Naoki Nihei; Hiroyoshi Suzuki; Atsushi Mizokami; Takeshi Ueda; Naohiko Seki; Hideki Tanzawa; Tomohiko Ichikawa
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240
View more
  7 in total

1.  Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer.

Authors:  Dorra BenAyed-Guerfali; Emna Dabbèche-Bouricha; Wajdi Ayadi; Fatma Trifa; Slim Charfi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Mol Biol Rep       Date:  2019-04-02       Impact factor: 2.316

2.  Time-varying effects of FOXA1 on breast cancer prognosis.

Authors:  Qian-Xin Chen; Yuan-Zhong Yang; Zhuo-Zhi Liang; Jia-Li Chen; Yue-Lin Li; Zi-Yi Huang; Zi-Jin Weng; Xiao-Fang Zhang; Jie-Xia Guan; Lu-Ying Tang; Jing-Ping Yun; Ze-Fang Ren
Journal:  Breast Cancer Res Treat       Date:  2021-02-18       Impact factor: 4.872

Review 3.  MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers.

Authors:  Chen Li; Kai Zhang; Jing Chen; Longbang Chen; Rui Wang; Xiaoyuan Chu
Journal:  Oncotarget       Date:  2017-02-14

4.  Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.

Authors:  Matthew P Humphries; Sreekumar Sundara Rajan; Hedieh Honarpisheh; Gabor Cserni; Jo Dent; Laura Fulford; Lee B Jordan; J Louise Jones; Rani Kanthan; Maria Litwiniuk; Anna Di Benedetto; Marcella Mottolese; Elena Provenzano; Sami Shousha; Mark Stephens; Janina Kulka; Ian O Ellis; Akinwale N Titloye; Andrew M Hanby; Abeer M Shaaban; Valerie Speirs
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

5.  FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers.

Authors:  Nihel Ammous-Boukhris; Wajdi Ayadi; Mariem Derbel; Nesrine Allaya-Jaafar; Slim Charfi; Jamel Daoud; Tahya Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Biomed Res Int       Date:  2020-06-22       Impact factor: 3.411

6.  FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.

Authors:  Nelson Rangel; Nicoletta Fortunati; Simona Osella-Abate; Laura Annaratone; Claudio Isella; Maria Graziella Catalano; Letizia Rinella; Jasna Metovic; Renzo Boldorini; Davide Balmativola; Pietro Ferrando; Francesca Marano; Paola Cassoni; Anna Sapino; Isabella Castellano
Journal:  BMC Cancer       Date:  2018-07-03       Impact factor: 4.430

7.  Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.

Authors:  Elie Dagher; Violette Royer; Paul Buchet; Jérôme Abadie; Delphine Loussouarn; Mario Campone; Frédérique Nguyen
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.